Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES ALKEM LABORATORIES VENUS REMEDIES/
ALKEM LABORATORIES
 
P/E (TTM) x 17.7 30.8 57.3% View Chart
P/BV x 0.8 6.5 12.4% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 VENUS REMEDIES   ALKEM LABORATORIES
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-24
ALKEM LABORATORIES
Mar-24
VENUS REMEDIES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4305,519 7.8%   
Low Rs1633,211 5.1%   
Sales per share (Unadj.) Rs449.91,059.4 42.5%  
Earnings per share (Unadj.) Rs21.3151.5 14.1%  
Cash flow per share (Unadj.) Rs41.1176.5 23.3%  
Dividends per share (Unadj.) Rs040.00 0.0%  
Avg Dividend yield %00.9 0.0%  
Book value per share (Unadj.) Rs364.7860.8 42.4%  
Shares outstanding (eoy) m13.37119.57 11.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.74.1 16.0%   
Avg P/E ratio x13.928.8 48.2%  
P/CF ratio (eoy) x7.224.7 29.2%  
Price / Book Value ratio x0.85.1 16.0%  
Dividend payout %026.4 0.0%   
Avg Mkt Cap Rs m3,960521,910 0.8%   
No. of employees `000NANA-   
Total wages/salary Rs m66922,010 3.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,015126,676 4.7%  
Other income Rs m1163,108 3.7%   
Total revenues Rs m6,130129,784 4.7%   
Gross profit Rs m59621,240 2.8%  
Depreciation Rs m2642,993 8.8%   
Interest Rs m11,124 0.1%   
Profit before tax Rs m44620,231 2.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1622,117 7.6%   
Profit after tax Rs m28518,115 1.6%  
Gross profit margin %9.916.8 59.1%  
Effective tax rate %36.210.5 345.8%   
Net profit margin %4.714.3 33.1%  
BALANCE SHEET DATA
Current assets Rs m3,595104,116 3.5%   
Current liabilities Rs m79439,946 2.0%   
Net working cap to sales %46.650.7 91.9%  
Current ratio x4.52.6 173.7%  
Inventory Days Days2822 128.6%  
Debtors Days Days48965 752.6%  
Net fixed assets Rs m2,67336,485 7.3%   
Share capital Rs m134239 55.9%   
"Free" reserves Rs m4,742102,686 4.6%   
Net worth Rs m4,876102,925 4.7%   
Long term debt Rs m387400 96.7%   
Total assets Rs m6,268140,601 4.5%  
Interest coverage x475.919.0 2,505.2%   
Debt to equity ratio x0.10 2,041.4%  
Sales to assets ratio x1.00.9 106.5%   
Return on assets %4.613.7 33.3%  
Return on equity %5.817.6 33.2%  
Return on capital %8.520.7 41.1%  
Exports to sales %016.0 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA20,316 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m020,316 0.0%   
Fx outflow Rs m05,413 0.0%   
Net fx Rs m014,903 0.0%   
CASH FLOW
From Operations Rs m37319,481 1.9%  
From Investments Rs m-72-10,085 0.7%  
From Financial Activity Rs m-11-11,450 0.1%  
Net Cashflow Rs m277-2,075 -13.4%  

Share Holding

Indian Promoters % 41.8 55.7 75.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.2 28.2 4.2%  
FIIs % 1.2 9.0 13.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.2 44.3 131.3%  
Shareholders   19,557 74,744 26.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on VENUS REMEDIES vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VENUS REMEDIES vs ALKEM LABORATORIES Share Price Performance

Period VENUS REMEDIES ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day -2.62% -0.55% 1.23%
1-Month -10.44% -8.69% -0.24%
1-Year -20.70% 22.94% 43.62%
3-Year CAGR -10.73% 19.26% 20.35%
5-Year CAGR 66.32% 21.80% 26.24%

* Compound Annual Growth Rate

Here are more details on the VENUS REMEDIES share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of VENUS REMEDIES hold a 41.8% stake in the company. In case of ALKEM LABORATORIES the stake stands at 55.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VENUS REMEDIES and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, VENUS REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ALKEM LABORATORIES paid Rs 40.0, and its dividend payout ratio stood at 26.4%.

You may visit here to review the dividend history of VENUS REMEDIES, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.